Large-scale testing (Phase 3)Not Yet RecruitingNCT07164534
What this trial is testing
A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.
Who this might be right for
Uterine Cervical Neoplasm
Tata Memorial Hospital 316